Human Ovary Cancer Cells, Cryopreserved, offer researchers the opportunity to study this devastating disease and advance our understanding of its biology and potential treatments. With options of dissociated primary tumor cells, dissociated PDX tumor cells, associated fibroblast cells, and human ovary cancer cell lines characterized from PDX, these cells represent a valuable resource for investigating the mechanisms of ovarian cancer development, progression, and drug resistance. Whether studying cell signaling pathways, evaluating the efficacy of novel therapies, or developing personalized treatments, these cryopreserved cells provide a reliable and consistent model for in vitro experimentation.

Our primary tumor cells are derived from human ovary tumors, dissociated into single cells, and cryopreserved to maintain high viability and biological relevance. These cells are an essential tool for the study of ovarian cancer, including drug screening, biomarker discovery, and personalized medicine.

Our PDX tumor cells are derived from patient-derived xenografts, which are models that better recapitulate the biology and genetics of human tumors than traditional cell lines. These cells offer an excellent model for studying tumor biology, drug resistance, and personalized medicine.

Our associated fibroblasts are primary cells derived from the tumor microenvironment, including cancer-associated fibroblasts (CAFs) and normal fibroblasts. These cells are valuable for studying the interactions between tumor cells and their microenvironment and for developing new therapies that target the tumor microenvironment.

Finally, our characterized cell lines are derived from PDX tumors and have been thoroughly characterized for their genetic and phenotypic properties. These cell lines offer a stable and reliable model for studying ovarian cancer biology and drug screening.

All of our cryopreserved samples are thoroughly tested for quality, purity, and sterility, ensuring their safety and suitability for use in research, drug development, and therapeutic applications.

Order now to take advantage of the potential of human ovary cancer cells and accelerate your research.